Generation of tumor-specific CD4+ T helper lymphocytes for immunotherapy against malignant melanoma

被引：0
|
作者：
Boss, C. N. [1 ]
Kayser, S. [2 ]
Feuchtinger, T. [2 ]
Roecken, M. [1 ]
机构：
[1] Univ Tubingen, Hosp Dermatol, Tubingen, Germany
[2] Univ Tubingen, Childrens Hosp, Tubingen, Germany
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2012年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
606
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] Generation of tumor-specific CD4+, interferon-γ-producing T helper lymphocytes for immunotherapy against malignant melanoma
    Boss, C. N.
    Kayser, S.
    Feuchtinger, T.
    Roecken, M.
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (03) : e46 - e46
  • [2] Clinical grade generation of tumor-specific CD4+ T helper lymphocytes for adoptive immunotherapy against malignant melanoma-antigens
    Boss, C. N.
    Kayser, S.
    Rittig, S. Malaika
    Weide, B.
    Garbe, C.
    Feuchtinger, T.
    Roecken, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S129 - S129
  • [3] Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes
    Friedman, Kevin M.
    Prieto, Peter A.
    Devillier, Laura E.
    Gross, Colin A.
    Yang, James C.
    Wunderlich, John R.
    Rosenberg, Steven A.
    Dudley, Mark E.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (05) : 400 - 408
  • [4] Tumor-specific human CD4+ regulatory T cells and their ligands:: Implications for immunotherapy
    Wang, HY
    Lee, DA
    Peng, GY
    Guo, Z
    Li, YC
    Kiniwa, Y
    Shevach, EM
    Wang, RF
    IMMUNITY, 2004, 20 (01) : 107 - 118
  • [5] Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma
    Zheng, Chunxing
    Snow, Bryan E.
    Elia, Andrew J.
    Nechanitzky, Robert
    Dominguez-Brauer, Carmen
    Liu, Shaofeng
    Tong, Yin
    Cox, Maureen A.
    Focaccia, Enrico
    Wakeham, Andrew C.
    Haight, Jillian
    Tobin, Chantal
    Hodgson, Kelsey
    Gill, Kyle T.
    Ma, Wei
    Berger, Thorsten
    Heikenwaelder, Mathias
    Saunders, Mary E.
    Fortin, Jerome
    Leung, Suet Yi
    Mak, Tak W.
    NATURE CANCER, 2023, 4 (10) : 1437 - +
  • [6] Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma
    Chunxing Zheng
    Bryan E. Snow
    Andrew J. Elia
    Robert Nechanitzky
    Carmen Dominguez-Brauer
    Shaofeng Liu
    Yin Tong
    Maureen A. Cox
    Enrico Focaccia
    Andrew C. Wakeham
    Jillian Haight
    Chantal Tobin
    Kelsey Hodgson
    Kyle T. Gill
    Wei Ma
    Thorsten Berger
    Mathias Heikenwälder
    Mary E. Saunders
    Jerome Fortin
    Suet Yi Leung
    Tak W. Mak
    Nature Cancer, 2023, 4 : 1437 - 1454
  • [7] Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor
    Baxevanis, CN
    Voutsas, IF
    Tsitsilonis, OE
    Gritzapis, AD
    Sotiriadou, R
    Papamichail, M
    JOURNAL OF IMMUNOLOGY, 2000, 164 (07): : 3902 - 3912
  • [8] Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
    Goding, Stephen R.
    Wilson, Kyle A.
    Xie, Ying
    Harris, Kristina M.
    Baxi, Aparna
    Akpinarli, Akgul
    Fulton, Amy
    Tamada, Koji
    Strome, Scott E.
    Antony, Paul Andrew
    JOURNAL OF IMMUNOLOGY, 2013, 190 (09): : 4899 - 4909
  • [9] Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
    Xie, Ying
    Akpinarli, Akguel
    Maris, Charles
    Hipkiss, Edward L.
    Lane, Malcolm
    Kwon, Eun-Kyung M.
    Muranski, Pawel
    Restifo, Nicholas P.
    Antony, Paul Andrew
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (03): : 651 - 667
  • [10] Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells
    Church, Sarah E.
    Jensen, Shawn M.
    Antony, Paul A.
    Restifo, Nicholas P.
    Fox, Bernard A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (01) : 69 - 79
12345